If bioinformatics remains a “craft,” while molecular information is collected on an industrial scale, progress can only proceed slowly. Today’s life sciences companies face a critical need to move beyond first generation bioinformatics tools with new scientific information technology solutions like SciDB that scale analyses to an industrial capability.

First generation tools suffer from several shortcomings. They do not readily allow data to be searchable or sharable, thus precluding easy analysis. They separate data storage from computing—forcing too much time to be spent moving data instead of analyzing data. There is insufficient support for integrating diverse datasets; or scaling complex analytics.

As the platform for the National Center for Biotechnology Information’s 1000 Genomes Browser since October 2012, Paradigm4 comes to the life science space with a proven record. As a result, we have recently added customers who use large and diverse data sets to solve a wide range of problems from gene expression data mining, high throughput screening, and patient stratification. Among them is Complete Genomics, a life sciences company that has developed and commercialized a DNA sequencing platform.

Complete Genomics joins other industry leaders like Foundation Medicine, the National Institutes of Health, and Novartis who are using SciDB for collaborative, reproducible research.

To accelerate SciDB adoption in life sciences, we have just welcomed Dr. Zachary Pitluk to the Paradigm4 team. Zach comes to us with more than a dozen years of experience in the life sciences market from companies such as Bristol-Myers Squibb, Clontech, Definiens, and Proveris Scientific, among others.

For more information on how SciDB is helping companies in bioinformatics, watch this video with Alex Poliakov, Paradigm4 Solutions Architect, and Dr. Eric Neumann of Foundation Medicine.